TIAA CREF Investment Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-197,822
| Closed | -$673K | – | 3053 |
|
|
2018
Q3 | $673K | Sell |
197,822
-4,416
| -2% | -$15.9K | ﹤0.01% | 2600 |
|
|
2018
Q2 | $760K | Sell |
202,238
-2,505
| -1% | -$12.2K | ﹤0.01% | 2604 |
|
|
2018
Q1 | $837K | Hold |
204,743
| – | – | ﹤0.01% | 2520 |
|
|
2017
Q4 | $952K | Sell |
204,743
-27,581
| -12% | -$152K | ﹤0.01% | 2490 |
|
|
2017
Q3 | $1.65M | Buy |
232,324
+11,988
| +5% | +$86.2K | ﹤0.01% | 2268 |
|
|
2017
Q2 | $1.59M | Buy |
220,336
+7,576
| +4% | +$47.3K | ﹤0.01% | 2315 |
|
|
2017
Q1 | $1.31M | Sell |
212,760
-14,526
| -6% | -$79.6K | ﹤0.01% | 2380 |
|
|
2016
Q4 | $1.33M | Sell |
227,286
-10,862
| -5% | -$59.4K | ﹤0.01% | 2393 |
|
|
2016
Q3 | $1.26K | Sell |
238,148
-73,302
| -24% | -$395K | ﹤0.01% | 2416 |
|
|
2016
Q2 | $2.06M | Sell |
311,450
-12,645
| -4% | -$70.7K | ﹤0.01% | 2097 |
|
|
2016
Q1 | $1.51M | Sell |
324,095
-12,619
| -4% | -$50.4K | ﹤0.01% | 2237 |
|
|
2015
Q4 | $1.7M | Sell |
336,714
-11,384
| -3% | -$54.1K | ﹤0.01% | 2270 |
|
|
2015
Q3 | $1.23M | Sell |
348,098
-14,863
| -4% | -$99.5K | ﹤0.01% | 2445 |
|
|
2015
Q2 | $3.62M | Buy |
362,961
+21,810
| +6% | +$234K | ﹤0.01% | 1913 |
|
|
2015
Q1 | $4.34M | Buy |
341,151
+21,886
| +7% | +$281K | ﹤0.01% | 1738 |
|
|
2014
Q4 | $4.52M | Sell |
319,265
-20,649
| -6% | -$320K | ﹤0.01% | 1693 |
|
|
2014
Q3 | $4.67M | Sell |
339,914
-8,882
| -3% | -$136K | ﹤0.01% | 1661 |
|
|
2014
Q2 | $5.36M | Buy |
348,796
+8,706
| +3% | +$123K | ﹤0.01% | 1649 |
|
|
2014
Q1 | $5.79M | Buy |
340,090
+13,245
| +4% | +$200K | ﹤0.01% | 1512 |
|
|
2013
Q4 | $4.23M | Sell |
326,845
-1,265
| -0.4% | -$15.1K | ﹤0.01% | 1761 |
|
|
2013
Q3 | $3.31M | Sell |
328,110
-14,713
| -4% | -$131K | ﹤0.01% | 1883 |
|
|
2013
Q2 | $2.56M | Buy |
+342,823
| New | +$2.68M | ﹤0.01% | 2008 |
|
TIAA CREF Investment Management's KERX Position: Q4 2018 in Review
TIAA CREF Investment Management sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 197,822 shares — an estimated $673K sold.
TIAA CREF Investment Management first reported a position in KERX in Q2 2013 and held it in 22 quarters. The position peaked at $5.79M in Q1 2014. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.
- TIAA CREF Investment Management reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
- TIAA CREF Investment Management sold 197,822 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $673K.
- TIAA CREF Investment Management first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 22 quarters.
- TIAA CREF Investment Management's Keryx Biopharmaceuticals Inc position peaked at $5.79M in Q1 2014.
- 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.
Based on TIAA CREF Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.